CYP21A2 and polycystic ovary syndrome: No differences in heterozygosity for CYP21A2 variants was found among adolescent diagnosed with PCOS, adolescents at risk of PCOS, or healthy controls; however, one limitation of this study is that it does not appear that V281L mutation was assayed [82].